ProfileGDS5822 / ILMN_1259431
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 2% 1% 4% 1% 5% 4% 20% 29% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 15.82
GSM1276600PDAC Late Ablation Control 271
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 16.44
GSM1276603PDAC Late Ablation 22.31
GSM1276604PDAC Late Ablation 35.75
GSM1303940PDAC Late Ablation_anti-CTLA4 16.74
GSM1303941PDAC Late Ablation_anti-CTLA4 210.620
GSM1303942PDAC Late Ablation_anti-CTLA4 314.229